XML 26 R16.htm IDEA: XBRL DOCUMENT v3.25.4
Acquisitions
 3 Months Ended
Mar. 31, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Acquisitions Acquisitions
On February 2, 2024, we completed the acquisition of HealthBeacon PLC (“HealthBeacon”), a medical technology firm and strategic partner of the Company, for €6.9 million (approximately $7.5 million). The transaction was funded with cash on hand.

The acquisition of HealthBeacon was accounted for as a business combination using the acquisition method of accounting. The results of operations for HealthBeacon are included in the accompanying Consolidated Statements of Operations for the three months ended March 31, 2025 and in the comparable period from the acquisition date until March 31, 2024, in which HealthBeacon had $1.5 million and $0.6 million in revenue, respectively, and $0.7 million and $1.1 million in operating loss, respectively. Pro forma financial information has not been presented, as revenue and expenses related to the acquisition do not have a material impact on the Company’s unaudited consolidated financial statements.

The purchase price allocation for HealthBeacon is final as of December 31, 2024.

During the three months ended March 31, 2024, we incurred transaction costs of approximately $1.0 million, which are included in Selling, general and administrative expenses. There were no transactions costs during the three months ended March 31, 2025.
The following table presents the final value of assets acquired and liabilities assumed:
Fair Values as of
February 2, 2024
Cash and cash equivalents$147 
Current assets1,452 
Property, plant and equipment, net6,634 
Goodwill847 
Other intangible assets, net1,111 
Total assets acquired10,191 
Liabilities, current2,016 
Liabilities, non-current616 
Total liabilities acquired2,632 
Purchase Price$7,559